Boston Scientific Corporation vs Cintas Corporation — how do they compare? Boston Scientific Corporation trades at $50.99 (market cap $74.19B), while Cintas Corporation trades at $205.28 (market cap $82.15B). The key difference: Boston Scientific Corporation and Cintas Corporation are close in size by market cap, and Cintas Corporation pays a 1.01% dividend while Boston Scientific Corporation pays none. Which is the better fit depends on your goals.
| BSX | CTAS | |
|---|---|---|
Market Cap | $74.19B | $82.15B |
Sector | Health | Industrials |
52-Week High | $108.14 | $225.10 |
52-Week Low | $42.63 | $163.55 |
Enterprise Value | $86.27B | $84.56B |
Dividend Yield | — | 1.01% |
Trailing returns across standard periods
Latest headlines on both assets
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →In its core uniform and facility services unit (78% of sales), Cintas provides uniform rental programs to businesses across the size spectrum, mostly in North America. The firm is by far the largest provider in the industry. Facilities products generally include the rental and sale of entrance mat, mops, shop towels, hand sanitizers, and restroom supplies. Cintas also runs a first aid and safety services business (11% of sales), a fire protection services business (7% of sales), and a uniform direct sales business (4% of sales).
Read more on CTAS →